Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
WuXi Biologics Launches WuXia ADCC PLUS™ to Advance the Development and Manufacturing of Afucosylated Antibodies, Enhancing ADCC Effect
Thursday, January 25, 2024WuXi Biologics has unveiled WuXiaADCC PLUSTM an innovative mammalian cell line platform for developing and manufacturing afucosylated antibodies that enhance AntibodyDependent CellMediated Cytotoxicity
Jiangsu Alphamab Biopharmaceuticals, 3D Medicines (Beijing), and Glenmark have signed a License Agreement for KN035 (Envafolimab) to be Distributed Globally
Thursday, January 25, 2024Glenmark Specialty SA a subsidiary of Glenmark Pharmaceuticals Ltd recently inked a license agreement with JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD and D MEDICINES CO LTD collectively referred to as the Licensors
Sciwind Biosciences Announces Encouraging Results From the Phase 1 Clinical Trial of XW004, an Oral Formulation of the Long-acting GLP-1 Analog Ecnoglutide
Wednesday, January 24, 2024Sciwind Biosciences Co Ltd a clinicalstage biopharmaceutical company focused on developing innovative therapies for metabolic diseases has reported positive interim results from the initial four cohorts of a Phase clinical trial
PharmAbcine Initiates Phase 1a/b Trial for PMC-309 with KEYTRUDA in Advanced Solid Tumors; First Dose Administered Successfully
Wednesday, January 24, 2024PharmAbcine Inc has officially initiated patient dosing in the Phase ab clinical trial of PMC a novel IgG monoclonal antibody designed for nextgeneration antibody therapeutics
NK CellTech Obtains FDA Clearance for NK010 Clinical Trial
Tuesday, January 23, 2024NK CellTech Co Ltd a leading biotechnology company specializing in the development of NK cellular therapies is excited to announce that the FDA has granted clearance for the clinical trial of NK a groundbreaking nongenetically modified natural killer...
Galderma Has Received Regulatory Approval for Restylane® SHAYPE™, a Novel Hyaluronic Acid Injectable Designed for Enhancing the Chin Region
Monday, January 22, 2024Galderma a leading player in the dermatology industry has recently obtained approval from Health Canada for its latest hyaluronic acid injectable Restylane SHAYPE This innovative product is specifically designed for temporary chin augmentation
The Sanyou Super Trillion Peptide Molecule Discovery Platform Was Officially Launched Today
Saturday, January 20, 2024Sanyou Biopharmaceuticals Co Ltd has officially introduced its stateoftheart Sanyou Super Trillion Peptide Molecule Discovery Platform
Eiger and Partner, AnGes, Gain Japan Approval for Zokinvy® in Progeria Syndromes
Friday, January 19, 2024Eiger BioPharmaceuticals Inc has recently announced that it in collaboration with AnGes Inc has secured marketing approval from the Ministry of Health Labour and Welfare in Japan for Zokinvy
Halozyme Announces That Argenx Has Obtained Approval in Japan for VYVDURA® (Efgartigimod Alfa and Hyaluronidase-qvfc) Co-formulated With ENHANZE®
Friday, January 19, 2024Halozyme Therapeutics Inc has announced that Japans Ministry of Health Labour and Welfare MHLW has granted approval for VYVDURA injection
Windtree Therapeutics and Lee's Pharmaceuticals License Istaroxime, Dual SERCA2a Activators, and Rostafuroxin for Greater China/Asia Pacific
Thursday, January 18, 2024Windtree Therapeutics Inc a biotechnology company specializing in advanced interventions for critical cardiovascular disorders has recently announced a license agreement with Lees Pharmaceutical
